Quinoline derivative for treating gastric cancer
US10736887B2 · kind B2 · utility
1Cited by
11References
13Claims
0Family size
Inventors
Key dates
| Filing date | Apr 14, 2017 |
| Grant date | Aug 11, 2020 |
| Priority date | — |
| Expiry date | Apr 14, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K45/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided in the present invention is a quinoline derivative for treating gastric cancer. 1-[[[4-(4-fluoro-2-methyl-1H-indol-5-yl)oxy-6-methoxyquinolin-7-yl]oxy]methyl]cyclopropylamine or a pharmaceutically acceptable salt, a hydrate or a prodrug thereof as provided in the present application can effectively treat gastric cancer, and can stabilize or relieve the state of illness of a gastric cancer patient.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.